Illinois 104th General Assembly Status: Introduced 5 D cosponsors

HB4065      — 340B GRANTEE CONTRACT ACCESS

Last action — House Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the House. Introduced May 22, 2025. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Not enough signal yet

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Creates the 340B Grantee Contract Pharmacy Access Act. Provides that no person, including a pharmaceutical manufacturer, may deny, restrict, or otherwise limit the acquisition of a 340B drug by a 340B grantee or a 340B contract pharmacy authorized to receive 340B drugs on behalf of the 340B grantee unless the acquisition is prohibited by federal law. Provides that the Department of Financial and Professional Regulation is authorized to enforce the Act and investigate possible violations of the Act by any person, including a pharmaceutical manufacturer. Sets forth provisions concerning preemption. Effective immediately.

Bill Text

We don't have the full text on file for this bill yet.

Read HB4065 on the official Illinois source →

Action History

  1. House Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee

  2. Rule 19(a) / Re-referred to Rules Committee

  3. House Committee Amendment No. 1 Rules Refers to Executive Committee

  4. House Committee Amendment No. 1 Referred to Rules Committee

  5. House Committee Amendment No. 1 Filed with Clerk by Rep. Rita Mayfield

  6. Assigned to Executive Committee

  7. Added Co-Sponsor Rep. Lisa Davis

  8. Added Co-Sponsor Rep. Thaddeus Jones

  9. Added Chief Co-Sponsor Rep. Debbie Meyers-Martin

  10. Added Chief Co-Sponsor Rep. Harry Benton

  11. Removed Co-Sponsor Rep. Harry Benton

  12. Added Co-Sponsor Rep. Harry Benton

  13. Referred to Rules Committee

  14. First Reading

  15. Filed with the Clerk by Rep. Rita Mayfield

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 4 co-sponsors · 178 not signed on

Sponsors (1)

Co-sponsors (4)

Not signed on (178)

178 members have not signed on to this bill.

Show all 178 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB4065      do?
Creates the 340B Grantee Contract Pharmacy Access Act. Provides that no person, including a pharmaceutical manufacturer, may deny, restrict, or otherwise limit the acquisition of a 340B drug by a 340B grantee or a 340B contract pharmacy authorized to receive 340B drugs on behalf of the 340B grantee unless the acquisition is prohibited by federal law. Provides that the Department of Financial and Professional Regulation is authorized to enforce the Act and investigate possible violations of the Act by any person, including a pharmaceutical manufacturer. Sets forth provisions concerning preemption. Effective immediately.
Who sponsors HB4065     ?
HB4065      is sponsored by Rita Mayfield (Democrat), Harry Benton (Democrat), Debbie Meyers-Martin (Democrat), Thaddeus Jones (Democrat), and Lisa Davis (Democrat).
What is the current status of HB4065     ?
This bill has been introduced in the House. Introduced May 22, 2025. It must pass committee before a floor vote.
Where can I track HB4065     ?
Track HB4065      free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB4065     

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB4065     

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →